Evaluation of an early step-down strategy from intravenous anidulafungin to oral azole therapy for the treatment of candidemia and other forms of invasive candidiasis: results from an open-label trial

BACKGROUND: Hospitalized patients are at increased risk for candidemia and invasive candidiasis (C/IC). Improved therapeutic regimens with enhanced clinical and pharmacoeconomic outcomes utilizing existing antifungal agents are still needed. METHODS: An open-label, non-comparative study evaluated an...

Descripción completa

Detalles Bibliográficos
Autores principales: Vazquez, Jose, Reboli, Annette C, Pappas, Peter G, Patterson, Thomas F, Reinhardt, John, Chin-Hong, Peter, Tobin, Ellis, Kett, Daniel H, Biswas, Pinaki, Swanson, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3944438/
https://www.ncbi.nlm.nih.gov/pubmed/24559321
http://dx.doi.org/10.1186/1471-2334-14-97

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3944438/
https://www.ncbi.nlm.nih.gov/pubmed/24559321
http://dx.doi.org/10.1186/1471-2334-14-97

Ejemplares similares